High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy

References

• Patterson C The state of the art of dementia research: new frontiers. An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International. World Alzheimer Report 2018. 2018.
   Google Scholar
• Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabet Endocrinol. 2014;2(3):246–255. doi:10.1016/S2213-8587(13)70088-3
   PubMed Web of Science ®Google Scholar
• Gupta P, Gan ATL, Man REK, et al. Association between diabetic retinopathy and incident cognitive impairment. Br J Ophthalmol. 2019;103(11):1605–1609. doi:10.1136/bjophthalmol-2018-312807
   PubMedGoogle Scholar
• Hafner A, Glavan G, Obermajer N, Živin M, Schliebs R, Kos J. Neuroprotective role of γ-enolase in microglia in a mouse model of Alzheimer’s disease is regulated by cathepsin X. Aging Cell. 2013;12(4):604–614. doi:10.1111/acel.12093
   PubMedGoogle Scholar
• Li J, Yan M, Zhang Y, Xie M, Yan L, Chen J. Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema. Diabet Med. 2015;32(1):102–107. doi:10.1111/dme.12597
   PubMed Web of Science ®Google Scholar
• Asadova V, Gul Z, Buyukuysal RL, Yalcinbayir O. Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy. Int Ophthalmol. 2020;40(1):227–234. doi:10.1007/s10792-019-01175-9
   PubMedGoogle Scholar
• Jones EL, Gauge N, Nilsen OB, et al. Analysis of neuron-specific enolase and S100B as biomarkers of cognitive decline following surgery in older people. Dement Geriatr Cogn Disord. 2012;34(5–6):307–311. doi:10.1159/000345538
   PubMedGoogle Scholar
• Baranyi A, Rothenhausler HB. The impact of S100b and persistent high levels of neuron-specific enolase on cognitive performance in elderly patients after cardiopulmonary bypass. Brain Inj. 2013;27(4):417–424. doi:10.3109/02699052.2012.750751
   PubMed Web of Science ®Google Scholar
• Silva FP, Schmidt AP, Valentin LS, et al. S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: a prospective observational study. Eur J Anaesthesiol. 2016;33(9):681–689. doi:10.1097/EJA.0000000000000450
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008
   PubMed Web of Science ®Google Scholar
• Tsai JC, Chen CW, Chu H, et al. Comparing the sensitivity, specificity, and predictive values of the montreal cognitive assessment and mini-mental state examination when screening people for mild cognitive impairment and dementia in Chinese population. Arch Psychiatr Nurs. 2016;30(4):486–491. doi:10.1016/j.apnu.2016.01.015
   PubMed Web of Science ®Google Scholar
• Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B. Post-mortem biochemistry of NSE and S100B: a supplemental tool for detecting a lethal traumatic brain injury? J Forensic Leg Med. 2018;55:65–73. doi:10.1016/j.jflm.2018.02.016
   PubMed Web of Science ®Google Scholar
• Mankovsky B, Zherdova N, van den Berg E, Biessels GJ, de Bresser J. Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus. Diabet Med. 2018;35(12):1663–1670. doi:10.1111/dme.13800
   PubMed Web of Science ®Google Scholar
• Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging. 2014;9:1011–1019. doi:10.2147/CIA.S48926
   PubMed Web of Science ®Google Scholar
• Lu X, Gong W, Wen Z, Hu L, Peng Z, Zha Y. Correlation between diabetic cognitive impairment and diabetic retinopathy in patients with T2DM by (1)H-MRS. Front Neurol. 2019;10:1068. doi:10.3389/fneur.2019.01068
   PubMedGoogle Scholar
• Li J, Zhang H, Xie M, Yan L, Chen J, Wang H. NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabetes Care. 2013;36(11):3405–3410. doi:10.2337/dc13-0590
   PubMed Web of Science ®Google Scholar
• Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–143.
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schonknecht P. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer’s disease. Neurosci Lett. 2014;570:81–85. doi:10.1016/j.neulet.2014.04.007
   PubMedGoogle Scholar
• Yuan XY, Wang XG. Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: a review. Rev Neurosci. 2017;28(7):715–723. doi:10.1515/revneuro-2017-0016
   PubMed Web of Science ®Google Scholar
• Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis. 2012;30(Suppl 2):S185–198. doi:10.3233/JAD-2012-111433
   PubMedGoogle Scholar
• Wium-Andersen IK, Rungby J, Jorgensen MB, Sandbaek A, Osler M, Wium-Andersen MK. Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose. Epidemiol Psychiatr Sci. 2019;29:e43. doi:10.1017/S2045796019000374
   PubMed Web of Science ®Google Scholar
• Umegaki H, Iimuro S, Shinozaki T, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int. 2012;12(Suppl 1):110–116. doi:10.1111/j.1447-0594.2011.00818.x
   PubMedGoogle Scholar
• Huang L, Yang L, Shen X, Yan S. Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes. Metab Brain Dis. 2016;31(2):347–353. doi:10.1007/s11011-015-9756-z
   PubMed Web of Science ®Google Scholar
• Kim C, Sohn J-H, Jang MU, et al. Association between visit-to-visit glucose variability and cognitive function in aged type 2 diabetic patients: a cross-sectional study. PLoS One. 2018;35(12):e0132118. doi:10.1371/journal.pone.0132118
   Google Scholar
• Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23):2551–2561. doi:10.1001/jama.2014.13806
   PubMed Web of Science ®Google Scholar